Transforming Women’s Health Through Science, Action, and CollaborationTogether with communities, researchers, health care providers, and policymakers, WINGS-4-FGS is finding ways to effectively detect and treat the neglected disease Female Genital Schistosomiasis (FGS) and giving women and girls the health and dignity they deserve.Discover Our Story
Transforming Women’s Health Through Science, Action, and CollaborationTogether with communities, researchers, health care providers, and policymakers, WINGS-4-FGS is finding ways to effectively detect and treat the neglected disease Female Genital Schistosomiasis (FGS) and giving women and girls the health and dignity they deserve.Discover Our Story
ENEN
FRFR

Université Félix Houphouët-Boigny

Université Félix Houphouët-Boigny (officially established on October 1, 1963), located in Abidjan (economic capital) on a vast 200-hectare campus, is one of the most prestigious universities in French-speaking West Africa. It is the first public university in Côte d’Ivoire. Université Félix Houphouët-Boigny offers a wide range of courses through its faculties: Biosciences, Criminology, Arts and Communication, Languages and Civilizations, Mathematics and Computer Science, Dentistry, Economics and Management Sciences, Law and Political Sciences, Medicine, Pharmacy, Science and Technology, and Earth and Mining Sciences. Université Félix Houphouët-Boigny has 50,000 students and comprises 13 training and research units, 33 research laboratories, 10 research institutes and centers, and four doctoral schools. A key player in the socio-economic and cultural development of Côte d'Ivoire, Université Félix-Houphouët-Boigny carries out teaching and research missions. UFHB has extensive experience in large-scale international collaborative research, contributing to clinical trials and major multi-country projects.

Role within WINGS-4-FGS

Université Félix Houphouët-Boigny (UFHB) is participating in the design of the study protocol and manuals, as well as all aspects of data collection. This includes implementing community surveys to assess population knowledge about FGS and raising awareness at multiple levels (health care workers, communities, etc.). It also includes assessing the feasibility of a community-based FGS diagnostic procedure to facilitate management. In addition, UFHB will participate in participant recruitment to evaluate the efficacy and safety of anti-inflammatory drugs combined with praziquantel, aiming to introduce a new approach to the management of FGS-associated morbidity. UFHB will collaborate with national and local health authorities to build the capacity of health professionals and assess barriers and facilitators to the integration of FGS management into existing health services. UFHB will finally contribute to communication and dissemination of the study results.

Dr Mamadou Ouattara
Dr Mamadou Ouattara
“WINGS-4-FGS project is collaborative research for the reduction of suffering and stigmatization of women with female genital schistosomiasis”
Dr Diakité N’Goran Nana Rose
Dr Diakité N’Goran Nana Rose
“WINGS-4-FGS is an initiative designed to bring hope to our courageous women who face their challenges quietly.”
Dr Fidèle Kouakou BASSA
Dr Fidèle Kouakou BASSA
“This project aligns with the Sustainable Development Goals (SDGs), which aim to improve the lives of vulnerable populations through international cooperation on issues like poverty, inequality, and health.”
Dr Gaoussou Coulibaly
Dr Gaoussou Coulibaly
“With WINGS-4-FGS project, we will track down a Neglected Tropical Disease for the well-being of remote populations.”
Dr Jules N. Kouadio
Dr Jules N. Kouadio
“This project provides an opportunity to generate evidence on the neglected Female Genital Schistosomiasis and to inform strategies for protecting the health of girls and women.”